Real-world effectiveness and safety of fingolimod in patients with multiple sclerosis in the Czech Republic: results from core and extension parts of the GOLEMS study up to 48 months
Doc Wire News,
This article was originally published here BMC Neurol. 2022 Apr 15;22(1):143. doi: 10.1186/s12883-022-02656-8.